BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18198203)

  • 1. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care.
    Delaney EK; Murchie P; Lee AJ; Ritchie LD; Campbell NC
    Heart; 2008 Nov; 94(11):1419-23. PubMed ID: 18198203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomized trial in primary care.
    Murchie P; Campbell NC; Ritchie LD; Deans HG; Thain J
    Fam Pract; 2004 Oct; 21(5):567-74. PubMed ID: 15367480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care.
    Murchie P; Campbell NC; Ritchie LD; Simpson JA; Thain J
    BMJ; 2003 Jan; 326(7380):84. PubMed ID: 12521974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial.
    Munoz MA; Vila J; Cabañero M; Rebato C; Subirana I; Sala J; Marrugat J;
    Int J Cardiol; 2007 Jun; 118(3):312-20. PubMed ID: 17261336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
    Ye P; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Am Geriatr Soc; 2007 Jul; 55(7):1015-22. PubMed ID: 17608873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study.
    Tenkanen L; Mänttäri M; Kovanen PT; Virkkunen H; Manninen V
    Arch Intern Med; 2006 Apr; 166(7):743-8. PubMed ID: 16606810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering effective primary care to older adults: a randomized, controlled trial of the senior resource team at group health cooperative.
    Phelan EA; Balderson B; Levine M; Erro JH; Jordan L; Grothaus L; Sandhu N; Perrault PJ; Logerfo JP; Wagner EH
    J Am Geriatr Soc; 2007 Nov; 55(11):1748-56. PubMed ID: 17979898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
    Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
    Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care.
    Campbell NC; Ritchie LD; Thain J; Deans HG; Rawles JM; Squair JL
    Heart; 1998 Nov; 80(5):447-52. PubMed ID: 9930042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
    Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).
    Gulliksson M; Burell G; Vessby B; Lundin L; Toss H; Svärdsudd K
    Arch Intern Med; 2011 Jan; 171(2):134-40. PubMed ID: 21263103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of nurse-led cardiac clinics in adult patients with a diagnosis of coronary heart disease.
    Page T; Lockwood C; Conroy-Hiller T
    Int J Evid Based Healthc; 2005 Feb; 3(1):2-26. PubMed ID: 21631742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
    Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
    Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
    Milano AF; Singer RB
    J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women.
    Zhu K; Devine A; Dick IM; Prince RL
    Spine (Phila Pa 1976); 2007 Aug; 32(18):2012-8. PubMed ID: 17700450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study.
    Wulsin LR; Evans JC; Vasan RS; Murabito JM; Kelly-Hayes M; Benjamin EJ
    Psychosom Med; 2005; 67(5):697-702. PubMed ID: 16204426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).
    Booth J; Clayton T; Pepper J; Nugara F; Flather M; Sigwart U; Stables RH;
    Circulation; 2008 Jul; 118(4):381-8. PubMed ID: 18606919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
    Buchwald H; Rudser KD; Williams SE; Michalek VN; Vagasky J; Connett JE
    Ann Surg; 2010 Jun; 251(6):1034-40. PubMed ID: 20485136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.